Doctors had high hopes for several new drugs aimed at significantly reducing levels of lipoprotein(a), a molecule considered one of the major risk factors for cardiovascular diseases. However, the failure of one of the large clinical trials has raised new questions.
ISNA is a semi-official Iranian news agency (Iranian Students News Agency). This is a translation of that outlet's own report; it is the outlet's account, not Artesh's finding.
See what Iranian state media is saying today.
❓ Unknown
The Failure of a Drug That Was Supposed to Revolutionize Cholesterol Treatment
Just now
November 4, 2026
1 min read
📰 ISNA
📋 Key Takeaway
A promising drug aimed at reducing lipoprotein(a) levels has failed in a major clinical trial, leading to concerns among medical professionals about the future of cholesterol treatment. This development is significant as it impacts cardiovascular health strategies. The failure raises questions about the efficacy of new treatments in this area.
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%
📰 Related Coverage
6 min ago •
Iran's November 4th Rally Draws Regional Media Attention
7 min ago •
Faribad Naderi and Hamed Behdad Heading to Theaters
7 min ago •
The Green Glass Hall Remains
7 min ago •
Judiciary Announcement Regarding Attribution of Some Fake Videos to the Head of the Judiciary
7 min ago •